Roll of yoga to improve the quality of life in breast cancer patients receiving chemotherapy

Not Applicable

• Conditions: 2013 ICD-1; breast cancer.; •A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males. -- 2003

• Registration Number: IRCT2013071513998N1
• Lead Sponsor: Islamic Azad University, Najafabad branch

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

1 - having age between 25 to 65 years, 2 - a consciousness, 3 - ability to communicate and interact appropriately in completing the questionnaire, 4 - Pathological diagnosis of breast cancer, 5 - willingness of patients to participate in study, 6 - Stage I and II breast cancer pathology, 7 - no metastasis or lymphatic metastasis zone, 8 - or complete a simple mastectomy, breast conservation surgery (lumpectomy,quadranetomy), 9 - two to six weeks after completion of chemotherapy and or radiation, 10 - Combination therapy: prescribing two or more chemotherapeutic agents for the treatment of cancer (and other performance enhancing drugs have a synergistic effect). 11 - External beam radiation (teletherapy): The patient has been exposed to radiation producing devices, 12 - not use other methods of complementary medicine at the time of the study, 13 - more than 2,500 white blood cells per cubic millimeter, 14 - Count platelets more than 50,000 per cubic millimeter, 15 - temperature less than 38.3 ° C or 101 ° F, 16 - no signs of infection and bleeding. Exclusion criteria for recurrence, disease duration less than 2 weeks, disorder comorbidity with other mental disorders, a history of cancer, previous surgery on the breast.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life. Timepoint: 8 weeks after intervention. Method of measurement: questionnaire Organization for Research and Treatment of Cancer Europe EORTC QLQ-C30)); and a standard questionnaire specifically to assess quality of life in breast cancer (EORTC QLQ-BR23);.